Body surface area in normal-weight, overweight, and obese adults. A comparison study.

[1]  Murilo Foppa,et al.  Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? , 2005, Cardiovascular ultrasound.

[2]  R. Habib,et al.  Effects of obesity and small body size on operative and long-term outcomes of coronary artery bypass surgery: a propensity-matched analysis. , 2005, The Annals of thoracic surgery.

[3]  H. Nomura,et al.  Body surface area is an independent factor contributing to the effects of lamivudine treatment. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  M. Michael,et al.  Implications of dose rounding of chemotherapy to the nearest vial size , 2003, Supportive Care in Cancer.

[5]  Deborah K Glencross,et al.  Multiple method comparison: Statistical model using percentage similarity , 2003, Cytometry. Part B, Clinical cytometry.

[6]  Wen-Ko Chiou,et al.  The 3D scanner for measuring body surface area: a simplified calculation in the Chinese adult. , 2003, Applied ergonomics.

[7]  S. Plein,et al.  Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady‐state free precession imaging sequences , 2003, Journal of magnetic resonance imaging : JMRI.

[8]  J. Verweij,et al.  Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxel. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J Verweij,et al.  Dosing strategies for anticancer drugs: the good, the bad and body-surface area. , 2002, European journal of cancer.

[10]  Thanh T Vu,et al.  Standardization of body surface area calculations , 2002 .

[11]  H. Gurney,et al.  How to calculate the dose of chemotherapy , 2002, British Journal of Cancer.

[12]  E. Livingston,et al.  Body surface area prediction in normal-weight and obese patients. , 2001, American journal of physiology. Endocrinology and metabolism.

[13]  S. Poole,et al.  Poor correlation between body surface area and glomerular filtration rate , 2000, Cancer Chemotherapy and Pharmacology.

[14]  Alireza Aslani,et al.  Body surface area: Du Bois and Du Bois revisited , 2000, European Journal of Applied Physiology.

[15]  L. Grochow,et al.  Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  L. Grochow,et al.  Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  F. Appelbaum,et al.  The impact of obesity and disease on busulfan oral clearance in adults. , 1999, Blood.

[18]  S. Allerheiligen,et al.  Preclinical, pharmacologic, and phase I studies of gemcitabine. , 1997, Seminars in oncology.

[19]  B. Bailey,et al.  Estimating the surface area of the human body. , 1996, Statistics in medicine.

[20]  S. Daniels,et al.  Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. , 1995, The American journal of cardiology.

[21]  J. Zalcberg,et al.  Lean body mass, body surface area and epirubicin kinetics. , 1994, Anti-cancer drugs.

[22]  Surface area estimation: pocket calculator v nomogram. , 1994, Archives of disease in childhood.

[23]  L. Grochow,et al.  Is dose normalization to weight or body surface area useful in adults? , 1990, Journal of the National Cancer Institute.

[24]  J A Mattar,et al.  A simple calculation to estimate body surface area in adults and its correlation with the Du Bois formula. , 1989, Critical care medicine.

[25]  L O Nwoye,et al.  Body surface area of Africans: a study based on direct measurements of Nigerian males. , 1989, Human biology.

[26]  T. K. Lam,et al.  More on simplified calculation of body-surface area. , 1988, The New England journal of medicine.

[27]  Mosteller Rd.  Simplified Calculation of Body-Surface Area , 1987 .

[28]  R. Gelman,et al.  Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agents. , 1987, Cancer treatment reports.

[29]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[30]  J. Boelaert,et al.  Should clearance be normalised to body surface or to lean body mass? , 1981, British journal of clinical pharmacology.

[31]  T. L. Evans,et al.  Kinetics of intravenous melphalan , 1979, Clinical pharmacology and therapeutics.

[32]  G. Siber,et al.  Predictability of peak serum gentamicin concentration with dosage based on body surface area. , 1979, The Journal of pediatrics.

[33]  G. Schwartz,et al.  Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. , 1978, The Journal of pediatrics.

[34]  E. Gehan,et al.  Estimation of human body surface area from height and weight. , 1970, Cancer chemotherapy reports.

[35]  E J Freireich,et al.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.

[36]  L. J. Krovetz,et al.  The physiologic significance of body surface area. , 1965, The Journal of pediatrics.

[37]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[38]  D. Pinkel.  The use of body surface area as a criterion of drug dosage in cancer chemotherapy. , 1958, Cancer research.

[39]  E. F. Bois,et al.  The Growth of the Surface Area of the Human Body. , 1936 .

[40]  D. DuBois,et al.  A formula to estimate the approximate surface area if height and weight be known , 1989 .

[41]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .